China
Africa
Explore chapters and articles related to this topic
Transvaginal Repair of Urogenital Fistula
Published in Linda Cardozo, Staskin David, Textbook of Female Urology and Urogynecology - Two-Volume Set, 2017
Barry G. Hallner, Kristi L. Hebert, J. Christian Winters
Figure 107.2 Cystoscopic evAluAtion often will demonstrAte the fistulA. In this figure, note the AbnormAl AppeAring tissue At the edge of the fistulA indicAted by blAck Arrow. biopsy noted A recurrence of vAginAl squAmous cell cArcinomA.
Factors that affect survival in vaginal cancer: a seer analysis
Published in Journal of Obstetrics and Gynaecology, 2022
Batuhan Bakirarar, Muberra Namli Kalem, Ziya Kalem
It is a natural outcome that survival time is longer in the presence of in situ vaginal cancer compared to invasive cancer. In the case of in situ cancer, survival time can be maintained using local surgical or ablative methods depending on patient’s overall medical condition, and lesion’s histological type and localisation (Hacker et al. 2015). Since such lesions are closely followed up, survival is longer compared to a primary invasive tumour once there is a transition to the invasive period (Dittmer et al. 2011). In a research covering the years 1996–2003, for in situ cases of vaginal squamous cell carcinoma, 5-year survival rate was 95.6% whereas it varied between 63.9% and 75.8% for invasive cases in connection with stage (Wu et al. 2008). Wolfson et al. (2016) showed in a SEER analysis that prognosis worsened with larger tumour diameter, but they excluded the insitu stage.
Human papillomavirus: present and future perspective in Saudi Arabia
Published in Journal of Obstetrics and Gynaecology, 2021
Squamous cell carcinoma represents about 90% of vaginal cancers (Hacker et al. 2015), and it is commonly attributed to infection with HPV. HPV-attributed vaginal squamous cell carcinoma is frequently preceded with vaginal intraepithelial neoplasia (VIN). HR-HPV 16 represents the major subtype associated with VIN and condylomata (Lamos et al. 2016). However, there is still a complete absence of data regarding the cancer of the vagina reported from Saudi Arabia.